Influence of Lymphangio vascular (V) and perineural (N) invasion on survival of patients with resected esophageal squamous cell carcinoma (ESCC): a single-center retrospective study
- PMID: 35256918
- PMCID: PMC8898008
- DOI: 10.7717/peerj.12974
Influence of Lymphangio vascular (V) and perineural (N) invasion on survival of patients with resected esophageal squamous cell carcinoma (ESCC): a single-center retrospective study
Abstract
Background: Lymphangio vascular invasion (LVI) and perineural invasion (PNI) are associated with survival following resection for gastrointestinal cancer. But the relationship between LVI/PNI and survival of esophageal squamous cell carcinoma (ESCC) is still unclear. We aim to demonstrate the prognostic significance of LVI/PNI in ESCC.
Methods: A total of 195 ESCC patients underwent curative surgery from 2012 to 2018 was collected in the 2nd Affiliated Hospital of Fujian Medical University. All the patients were divided into four groups based on the status of the neurovascular invasion: (1) neither LVI nor PNI (V0N0); (2) LVI alone (V1N0); (3) PNI alone (V0N1); (4) combined LVI and PNI (V1N1). First, the analysis included the Kaplan-Meier survival estimates with the Log rank test were performed to determine median overall survival (OS) in different groups divided according to the clinical factor, respectively. And the association between OS with multi clinical factors was examined using Cox regression analysis. Next, the risk factors for recurrence in patients with V1N1 were analyzed with univariate and multivariate logistic regression analyses, respectively.
Results: The cases in V0N0, V1N0, V0N1, and V1N1 groups were 91 (46.7%), 62 (31.8%), 9 (4.6%) and 33 (16.9%), respectively. The OS in the four groups was different (P < 0.001). The 1-, 3- and 5-year OS in V0N0 group was higher than that in V1N1 group, respectively (1-year OS: 93.4% vs 75.8%, 3-year OS: 53.8 % vs 24.2%, 5-year OS: 48.1% vs 10.5%). The OS in stage I-II for patients with V1N1 was significantly lower than that in the other groups (V0N0, V1N0, V0N1) (P < 0.001). The postoperative adjuvant chemotherapy was a significant impact factor of OS for ESCC patients with V1N1 (P = 0.004). Lymphatic invasion and LVI were significantly prognosis factors associated (P = 0.036, P = 0.030, respectively). The ulcerative type is a risk factor for V1N1 occurance (P = 0.040).
Conclusions: The LVI and PNI are important prognosis factors for ESCC patients. ESCC patients with simultaneous lymphangio vascular and perineural invasion (V1N1) showed worse OS than patients with either lymphangio vascular or perineural invasion alone (V1N0 or V0N1) or none (V0N0). In addition, adjuvant chemotherapy may prolong the OS for ESCC patients with V1N1.
Keywords: Esophageal squamous cell carcinoma; Lymphangio vascular invasion; Overall survival; Perineural invasion; Prognosis.
© 2022 Xie et al.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures




Similar articles
-
Perineural Invasion Is a Significant Indicator of High Malignant Degree and Poor Prognosis in Esophageal Cancer: A Systematic Review and Meta-Analysis.Front Oncol. 2022 Jun 8;12:816270. doi: 10.3389/fonc.2022.816270. eCollection 2022. Front Oncol. 2022. PMID: 35756642 Free PMC article.
-
The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma.Int J Clin Exp Pathol. 2015 Jun 1;8(6):6881-90. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26261575 Free PMC article.
-
Occurrence and Prognostic Value of Perineural Invasion in Esophageal Squamous Cell Cancer: A Retrospective Study.Ann Surg Oncol. 2022 Jan;29(1):586-597. doi: 10.1245/s10434-021-10665-z. Epub 2021 Aug 23. Ann Surg Oncol. 2022. PMID: 34426885
-
Lymphovascular Invasion as the Major Prognostic Factor in Node-Negative Esophageal Cancer After Primary Esophagectomy.J Gastrointest Surg. 2020 Jul;24(7):1459-1468. doi: 10.1007/s11605-019-04310-0. Epub 2019 Jul 3. J Gastrointest Surg. 2020. PMID: 31273552
-
Best additional management after non-curative endoscopic resection of esophageal squamous cell carcinoma: a systematic review and meta-analysis.Scand J Gastroenterol. 2022 May;57(5):525-533. doi: 10.1080/00365521.2021.2023627. Epub 2022 Jan 5. Scand J Gastroenterol. 2022. PMID: 34986068
Cited by
-
A preoperative pathological staging prediction model for esophageal cancer based on CT radiomics.BMC Cancer. 2025 Feb 19;25(1):298. doi: 10.1186/s12885-025-13697-w. BMC Cancer. 2025. PMID: 39972430 Free PMC article.
-
Impact of perineural invasion in thoracic esophageal squamous cell carcinoma-a retrospective study with long-term follow-up outcomes.J Thorac Dis. 2025 May 30;17(5):2989-3003. doi: 10.21037/jtd-2024-2043. Epub 2025 May 28. J Thorac Dis. 2025. PMID: 40529762 Free PMC article.
-
Neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma: a clinical retrospective study.BMC Cancer. 2025 Aug 5;25(1):1270. doi: 10.1186/s12885-025-14682-z. BMC Cancer. 2025. PMID: 40764546 Free PMC article.
-
Perineural Invasion Is a Significant Indicator of High Malignant Degree and Poor Prognosis in Esophageal Cancer: A Systematic Review and Meta-Analysis.Front Oncol. 2022 Jun 8;12:816270. doi: 10.3389/fonc.2022.816270. eCollection 2022. Front Oncol. 2022. PMID: 35756642 Free PMC article.
-
Association between tumor necrosis factor receptor 2 and progression and poor prognosis of tumor stage 2‑3 esophageal squamous cell carcinoma and stratified analysis.Oncol Lett. 2024 Aug 21;28(5):505. doi: 10.3892/ol.2024.14638. eCollection 2024 Nov. Oncol Lett. 2024. PMID: 39233825 Free PMC article.
References
-
- Ajani JA, D’Amico TA, Bentrem DJ, Chao J, Corvera C, Das P, Denlinger CS, Enzinger PC, Fanta P, Farjah F, Gerdes H, Gibson M, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Johung KL, Keswani RN, Kleinberg LR, Leong S, Ly QP, Matkowskyj KA, McNamara M, Mulcahy MF, Paluri RK, Park H, Perry KA, Pimiento J, Poultsides GA, Roses R, Strong VE, Wiesner G, Willett CG, Wright CD, McMillian NR, Pluchino LA. Esophageal and esophagogastric junction cancers, version 2.2019, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network. 2019;17:855–883. doi: 10.6004/jnccn.2019.0033. - DOI - PubMed
-
- Batsakis JG. Nerves and neurotropic carcinomas. Annals of Otology, Rhinology & Laryngology. 1985;94:426–427. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical